Tirzepatide is administered by injection under the skin once weekly, with the dose adjusted as tolerated to meet blood glucose goals and/or weight loss goals.
-
Patients who used tirzepatide lost an average of 18 percent of their body weight, according to the F.D.A ., when it was taken at its highest dose in a drug trial. That’s compared with Wegovy, manufactured by Novo Nordisk, which produced an average 15 percent weight loss.
- Tirzepatide can cause side effects such as nausea, diarrhea, vomiting, constipation, abdominal (stomach) discomfort and pain, injection site reactions, fatigue, hypersensitivity (allergic) reactions (typically fever and rash), burping, hair loss and gastroesophageal reflux disease.
- Zepbound should not be used in patients with a personal or family history of medullary thyroid cancer or in patients with Multiple Endocrine Neoplasia syndrome type 2.
Schedule a Consultation Today! Call 817-443-3729 or online at forever29medspa.com
Author
Nicole E. Tribble
Nicole Eason-Tribble, PA-C, is a medical aesthetic specialist at Forever29 MedSpa in Fort Worth, Texas. Nicole’s style of practice is holistic, artistic, and very personable – always based on medical science and protocols. People are very different, genetically, phenotypically and will be approached and treated as such. She does not use a cookie-cutter approach with her clients’ treatment plans. Nicole believes in educating her clients, and that with an informed client, you can achieve the best and most beautiful outcomes.
